MoonLake Immunotherapeutics
NASDAQ:MLTX
51.78 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -36.908 | -24.267 | -13.674 | -7.437 | -11.619 | -12.353 | -12.219 | -16.468 | -14.742 | -17.416 | -15.88 | -2.222 | -6.288 | -32.686 | -0.076 |
| Depreciation & Amortization
| 0.033 | 0.028 | 0.023 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.002 | 0.003 | 0.002 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0.037 | -0.024 | -0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 1.843 | 1.828 | 1.677 | 1.606 | 1.426 | 1.498 | 2.577 | 2.597 | 2.585 | 2.484 | 1.989 | 7.757 | 1.856 | 1.25 | 0 |
| Change In Working Capital
| 8.165 | -5.321 | -2.844 | -6.537 | 1.011 | -1.26 | 0.569 | 2.122 | 2.752 | -5.922 | -0.379 | 1.862 | 2.256 | 0 | -0.014 |
| Accounts Receivables
| 0.62 | -0.181 | -0.439 | -0.336 | -0.101 | -0.241 | -0.161 | 0 | -0 | 0 | -0.433 | -0.112 | -0.056 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 7.546 | -5.14 | -2.405 | -6.201 | 1.112 | -1.018 | 0.73 | 2.121 | 2.752 | -5.922 | 1.919 | 0.051 | 2.098 | 0 | -0.014 |
| Other Non Cash Items
| 1.593 | 1.907 | 2.031 | -0.016 | -0.047 | -0.033 | 0.046 | 0.15 | 0.05 | 0.09 | 0.082 | -0.002 | 0.156 | 31.435 | -0.018 |
| Operating Cash Flow
| -25.275 | -27.89 | -14.948 | -12.344 | -9.251 | -12.159 | -9.024 | -11.596 | -9.352 | -20.76 | -14.186 | -0.362 | -2.019 | 0.006 | -0.108 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| -0.132 | 0 | -0.212 | -0.285 | 0 | 0 | 0 | -0 | 0 | -0.016 | -0.016 | -0.029 | -0.012 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -29.18 | -86.442 | -87.713 | -175,556.978 | -175.733 | 0 | 0 | 0 | -42.226 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 87.594 | -1.301 | 59.121 | 117.151 | 1.357 | 12.676 | 19.649 | 9,901.437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -87.743 | -28.593 | 175,556.978 | -0.174 | 0.013 | 0.02 | -9,891.536 | -0.042 | 0.016 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 58.282 | -87.743 | -28.804 | 116.867 | -174.376 | 12.676 | 19.649 | 9.901 | -42.226 | 0 | -0.016 | -0.029 | -0.012 | 0 | 0 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.15 | -0.15 | 0 | 0 | 0 | -0.058 |
| Common Stock Issued
| -52.54 | 0 | 52.54 | 31.169 | 0 | 451.285 | 0 | -134.685 | 0 | 134.689 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.007 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 52.723 | 0 | -1.562 | -2.753 | 0 | 0.451 | 0 | 134.689 | 0 | 104.685 | 15.004 | 23.659 | 0.498 | 0 | 0 |
| Financing Cash Flow
| 0.183 | 0 | 50.978 | 28.416 | 0 | 451.285 | 0 | 0.004 | 0 | 104.685 | 15.004 | 23.651 | 0.498 | 0 | -0.058 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| -0.325 | -0.017 | 0.046 | 0.065 | 0.005 | -0.145 | -0.001 | -0.008 | 0.074 | -0.051 | -0.007 | 0.003 | -0.001 | 0 | 0 |
| Net Change In Cash
| 32.865 | -115.65 | 7.272 | 133.004 | -183.621 | 451.658 | 10.624 | -1.699 | -51.503 | 83.874 | 0.795 | -0.362 | -1.533 | 0.006 | -0.166 |
| Cash At End Of Period
| 375.656 | 342.791 | 458.441 | 451.169 | 318.166 | 501.787 | 50.129 | 39.506 | 41.205 | 92.708 | 8.834 | 0.667 | 0.508 | 0.006 | 1.17 |